CMS decision harms current and future treatment options for Alzheimer's and other chronic disease populations
April 8, 2022 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement from Chair Ken Thorpe regarding the Centers for Medicare and
March 01, 2022
Real Clear Policy
By Kenneth E. Thorpe
While the pandemic is by no means over, Covid-19 isn't the only threat to public health we face. In fact, it might not even be our most serious challenge.
Despite the tragic loss of more than 2,000 American
By Kenneth E. Thorpe
February 3, 2022
More than half of Oregon's population -- nearly 2.3 million people -- is living with at least one chronic disease.[1][2] A disproportionate share rely on Medicaid to provide them the medications they need, and are beneficiaries because of
WASHINGTON (December 7, 2021) -- Today, the Partnership to Fight Chronic Disease (PFCD) released the following statement following President Biden’s remarks on the costs of prescription drugs.
“Especially as Americans are still very much navigating a path forward from
WASHINGTON, D.C. (November 3, 2021) Today, the Partnership to Fight Chronic Disease (PFCD) released the following statement on the drug pricing plan that Congress is considering.
“While we wait to see the details of this plan, Senate negotiators have apparently taken some
By Kenneth Thorpe
10/24/21 AT 6:30 AM
Beating Covid-19 has certainly taken longer than most of us were hoping, but we've turned the corner, and it's never too early to begin the critical exercise of assessing "lessons learned."
Clearly, in numerous
BY PAT FURLONG , ANNIE KENNEDY & KEN THORPE
October 20, 2021 at 5:00 am ET
Today, you can go from hero to villain instantaneously. The Food and Drug Administration was rightfully applauded for efficiently reviewing COVID-19
PFCD’s ongoing advertisements elevate patient voices on oversights of current legislative proposals on truly lowering health care costs
WASHINGTON, D.C. (October 18, 2021) – The Partnership to Fight Chronic Disease (PFCD) today announced a new round of television and digital
Intellectual property protections help keep the world safe. Getting a drug successfully to market can cost billions of dollars and take several years of scientific toil. Blood, sweat, tears – and money. Fewer than one in 10 products that enter clinical trials are ever greenlit by the FDA. If
“There is much work still to be done to respond to COVID-19 that will likely continue for years to come, but we cannot lose momentum on preparing for the next emergency– the costs of doing otherwise are just too high.”
September 22, 2021 09:30 AM